Sutro Biopharma announces 1-for-10 reverse stock split effective Dec 3 to regain Nasdaq compliance

SUTRO BIOPHARMA, INC.

Reverse stock split at 1-for-10, effective 12:01 a.m. ET on December 3, 2025.
Outstanding shares reduced from ~85.2M to ~8.52M; symbol STRO unchanged, new CUSIP 869367201.
Intended to regain Nasdaq minimum bid price compliance; approved by stockholders on June 6, 2025.
No fractional shares issued; any fractional interest rounded up to nearest whole share.
Proportionate adjustments to equity awards, exercise prices, and shares reserved under equity plans.

item 3.03item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.